![PDF) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias PDF) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias](https://i1.rgstatic.net/publication/40045065_Tailoring_iron_chelation_by_iron_intake_and_serum_ferritin_The_prospective_EPIC_study_of_deferasirox_in_1744_patients_with_transfusion-dependent_anemias/links/0deec52099a9e36e42000000/largepreview.png)
PDF) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin | Haematologica
![IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia](https://www.mdpi.com/ijms/ijms-18-02778/article_deploy/html/images/ijms-18-02778-g001.png)
IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
![Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease](https://article.imrpress.com/journal/FBE/14/3/10.31083/j.fbe1403018/1945-0508-14-3-018/fig1.jpg)
Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease
![The evolving treatment landscape for children with sickle cell disease - The Lancet Child & Adolescent Health The evolving treatment landscape for children with sickle cell disease - The Lancet Child & Adolescent Health](https://www.thelancet.com/cms/attachment/96f2c482-874c-475a-8a66-9019e03aaa99/gr1_lrg.jpg)
The evolving treatment landscape for children with sickle cell disease - The Lancet Child & Adolescent Health
![Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates: Molecular Therapy - Methods & Clinical Development Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/b830f429-fd92-4dcf-974c-a5b8d42b393f/gr3.jpg)
Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates: Molecular Therapy - Methods & Clinical Development
![Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission - The Lancet Haematology Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission - The Lancet Haematology](https://www.thelancet.com/cms/attachment/8ea69c89-10c4-44c8-81ad-abcf8b3d7df2/gr1_lrg.jpg)
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission - The Lancet Haematology
![Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E/β-thalassemia patient | Scientific Reports Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E/β-thalassemia patient | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-73991-4/MediaObjects/41598_2020_73991_Fig1_HTML.png)
Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E/β-thalassemia patient | Scientific Reports
Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis | Haematologica
![Frontiers | Understanding blood development and leukemia using sequencing-based technologies and human cell systems Frontiers | Understanding blood development and leukemia using sequencing-based technologies and human cell systems](https://www.frontiersin.org/files/Articles/1266697/fmolb-10-1266697-HTML-r1/image_m/fmolb-10-1266697-g001.jpg)
Frontiers | Understanding blood development and leukemia using sequencing-based technologies and human cell systems
![Cells | Free Full-Text | Eltrombopag Improves Erythroid Differentiation in a Human Induced Pluripotent Stem Cell Model of Diamond Blackfan Anemia Cells | Free Full-Text | Eltrombopag Improves Erythroid Differentiation in a Human Induced Pluripotent Stem Cell Model of Diamond Blackfan Anemia](https://www.mdpi.com/cells/cells-10-00734/article_deploy/html/images/cells-10-00734-g001.png)
Cells | Free Full-Text | Eltrombopag Improves Erythroid Differentiation in a Human Induced Pluripotent Stem Cell Model of Diamond Blackfan Anemia
![Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia? Cancers | Free Full-Text | Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?](https://pub.mdpi-res.com/cancers/cancers-14-05655/article_deploy/html/images/cancers-14-05655-ag.png?1669187241)